Abstract:Background: To depict the immune infiltration characteristics of tumor cells in patients with lung adenocarcinoma (LUAD) and evaluate the predictive value and significance of tumor immune cells on the prognosis of LUAD patients. Methods: The clinical characteristics and transcriptome of LUAD patients were obtained from The Cancer Genome Atlas (TCGA), and the immune cell abundance in LUAD tissue was evaluated using the CIBERSORT algorithm. We created a simplified immune cell-based Cox regression model according to the survival status of patients and clarified the correlation between the survival status of patients and seven types of immune cells. An immune cell-based risk prediction model was created by Cox proportional hazards regression. Subsequently, the gene expression profile of LUAD patients was obtained from the Gene Expression Omnibus (GEO) database to validate the tumor immune infiltration and patient prognosis prediction model attained using the CIBERSORT algorithm. Results: The abundance of 22 tumor-infiltrating immune cells in these patients was detected using the CIBERSORT algorithm. According to Pearson correlation analysis, the immune cells appeared to be closely related to each other. The immune cell composition was remarkably different between the LUAD tumor tissue and paracancerous tissue. The simplified COX model showed that seven kinds of immune cells have predictive value for the prognosis and survival status of LUAD. The receiver operating characteristic curve (ROC) curve confirmed that the prediction model performed well for 1-, 3-, and 5-year survival status. The calibration curve suggested that the prediction model was consistent with the clinical results. Correlation analysis revealed that the clinical features were significantly related to immune cell infiltration. A total of 246 LUAD specimens were from the GEO database, and the risk score model suggested that high risk scores were indicative of a poor prognosis. Finally, enzyme-linked immunosorbent assay (ELISA) revealed that the expressions of tumor necrosis factor-alpha (TNF-alpha), interleukin 8 (IL-8), IL-6, and interferon-gamma (IFN-gamma) in tumor tissues were remarkably higher compared with those in adjacent tissues. Conclusions: There is a close correlation between the tumor-infiltrating immune cells and the prognosis and clinical characteristics of LUAD patients. The risk score model based on TCGA and GEO designed in this study can be applied in clinical practice.

The Prognostic and Immune Infiltration Role of ITGB Superfamily Members in Non-Small Cell Lung Cancer.

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Prognostic implication of ITGB8 and its relationship with immune response

Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer

What is the impact of ITGβ8 on NSCLC: A systematic study

The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer.

An Integrated Analysis of The Prognosis And Immune Cell Infiltration of ITGB Superfamily Members In Gastric Cancer

Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways

TFAP2A-activated ITGB4 Promotes Lung Adenocarcinoma Progression and Inhibits CD4+/CD8++ /Cd8+t-Cell Infiltrations by Targeting NF-κB Κ B Signaling Pathway

Immuno-histochemical Expression and Significance of Extracellular Matrix Proteins and Integrin β1 in Non-small Cell Lung Cancer

Integrated analysis highlights the significance role of ITGAL in lung adenocarcinoma

TFAP2A-activated ITGB4 promotes lung adenocarcinoma progression and inhibits CD4+/CD8+ T-cell infiltrations by targeting NF-κB signaling pathway

Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1

High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer

ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates

Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)

ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis

Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network

A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma

The Relationship Between Tumor Infiltrating Immune Cells and the Prognosis of Patients with Lung Adenocarcinoma.

Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer